Inconsistency in steroid use as antiemetics in clinical trial protocols involving immune checkpoint inhibitors combined with chemotherapy

ConclusionThe research highlights the lack of uniformity in antiemetic steroid use in trials, reflecting diverse clinical practices and underscoring the need for further research to understand the implications on treatment outcomes.

Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Soh Mee Park, Yu Jung Kim, Ju ‐Yeun Lee Tags: BRIEF COMMUNICATION Source Type: research